GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » Price-to-Tangible-Book

Vivoryon Therapeutics NV (FRA:05Y) Price-to-Tangible-Book : 2.70 (As of Jun. 07, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV Price-to-Tangible-Book?

As of today (2024-06-07), Vivoryon Therapeutics NV's share price is €2.62. Vivoryon Therapeutics NV's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €0.97. Hence, Vivoryon Therapeutics NV's Price to Tangible Book Ratio of today is 2.70.

The historical rank and industry rank for Vivoryon Therapeutics NV's Price-to-Tangible-Book or its related term are showing as below:

FRA:05Y' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.46   Med: 9.31   Max: 23.78
Current: 2.65

During the past 13 years, Vivoryon Therapeutics NV's highest Price to Tangible Book Ratio was 23.78. The lowest was 2.46. And the median was 9.31.

FRA:05Y's Price-to-Tangible-Book is ranked better than
51.81% of 1218 companies
in the Biotechnology industry
Industry Median: 2.79 vs FRA:05Y: 2.65

A closely related ratio is called PB Ratio. As of today, Vivoryon Therapeutics NV's share price is €2.62. Vivoryon Therapeutics NV's Book Value per Sharefor the quarter that ended in Dec. 2023 was €1.01. Hence, Vivoryon Therapeutics NV's P/B Ratio of today is 2.60.


Vivoryon Therapeutics NV Price-to-Tangible-Book Historical Data

The historical data trend for Vivoryon Therapeutics NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivoryon Therapeutics NV Price-to-Tangible-Book Chart

Vivoryon Therapeutics NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.40 7.11 23.80 9.58 8.61

Vivoryon Therapeutics NV Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.80 7.01 9.58 7.77 8.61

Competitive Comparison of Vivoryon Therapeutics NV's Price-to-Tangible-Book

For the Biotechnology subindustry, Vivoryon Therapeutics NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivoryon Therapeutics NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivoryon Therapeutics NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Vivoryon Therapeutics NV's Price-to-Tangible-Book falls into.



Vivoryon Therapeutics NV Price-to-Tangible-Book Calculation

Vivoryon Therapeutics NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=2.62/0.972
=2.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Vivoryon Therapeutics NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Vivoryon Therapeutics NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivoryon Therapeutics NV (FRA:05Y) Business Description

Traded in Other Exchanges
Address
Weinbergweg 22, Halle, SN, DEU, 06120
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV (FRA:05Y) Headlines

No Headlines